Overexpression or amplification of human epidermal growth factor receptor 2 (HER2) in bladder cancer correlates with tumor progression and poor prognosis, particularly being more prevalent in lymph node metastases (93). Here, ERBB2 is linked to urinary bladder carcinoma.